- Home
- SUPN vs PGNY Comparison
SUPN vs PGNY Comparison
Compare SUPN & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- PGNY
- Stock Information
- Founded
- SUPN 2005
- PGNY 2008
- Country
- SUPN United States
- PGNY United States
- Employees
- SUPN N/A
- PGNY N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- PGNY Misc Health and Biotechnology Services
- Sector
- SUPN Health Care
- PGNY Health Care
- Exchange
- SUPN Nasdaq
- PGNY Nasdaq
- Market Cap
- SUPN 1.8B
- PGNY 1.8B
- IPO Year
- SUPN 2012
- PGNY 2019
- Fundamental
- Price
- SUPN $31.91
- PGNY $21.70
- Analyst Decision
- SUPN Hold
- PGNY Buy
- Analyst Count
- SUPN 2
- PGNY 8
- Target Price
- SUPN $36.00
- PGNY $22.43
- AVG Volume (30 Days)
- SUPN 460.6K
- PGNY 1.2M
- Earning Date
- SUPN 05-06-2025
- PGNY 05-08-2025
- Dividend Yield
- SUPN N/A
- PGNY N/A
- EPS Growth
- SUPN N/A
- PGNY N/A
- EPS
- SUPN 1.11
- PGNY 0.57
- Revenue
- SUPN $667,997,000.00
- PGNY $1,213,181,000.00
- Revenue This Year
- SUPN N/A
- PGNY $6.75
- Revenue Next Year
- SUPN $8.74
- PGNY $11.16
- P/E Ratio
- SUPN $28.64
- PGNY $38.43
- Revenue Growth
- SUPN 11.82
- PGNY 9.46
- 52 Week Low
- SUPN $25.53
- PGNY $13.39
- 52 Week High
- SUPN $40.28
- PGNY $30.42
- Technical
- Relative Strength Index (RSI)
- SUPN 47.71
- PGNY 49.34
- Support Level
- SUPN $31.56
- PGNY $20.95
- Resistance Level
- SUPN $32.85
- PGNY $22.03
- Average True Range (ATR)
- SUPN 0.78
- PGNY 0.67
- MACD
- SUPN -0.08
- PGNY -0.02
- Stochastic Oscillator
- SUPN 24.38
- PGNY 59.30
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.